Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria

Fig. 1

Comparisons of proteinuria, renal function and urinary FABPs among kidney diseases. a-d. Comparisons of levels of proteinuria (a), estimated glomerular filtration rate (eGFR) (b), urinary fatty acid-binding protein 4 (U-FABP4) (c) and urinary fatty acid-binding protein 1 (U-FABP1) (d) in patients with IgA nephropathy/IgA vasculitis (IgAN/IgAV, n = 26), minor glomerular abnormalities (MGA, n = 15), minimal change nephrotic syndrome (MCNS, n = 9), membranous nephropathy (MN, n = 12), diabetic nephropathy (DN, n = 4) and others (n = 15). *P < 0.05 vs. IgAN/IgAV, †P < 0.05 vs. MGA, ‡P < 0.05 vs. MCNS, §P < 0.05 vs. MN, ||P < 0.05 vs. DN

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us